NEGX.F Stock Overview
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
NexgenRx Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.20 |
| 52 Week High | CA$0.20 |
| 52 Week Low | CA$0.18 |
| Beta | 0.29 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 5.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEGX.F | US Insurance | US Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | -2.1% |
| 1Y | n/a | 32.5% | 29.6% |
Return vs Industry: Insufficient data to determine how NEGX.F performed against the US Insurance industry.
Return vs Market: Insufficient data to determine how NEGX.F performed against the US Market.
Price Volatility
| NEGX.F volatility | |
|---|---|
| NEGX.F Average Weekly Movement | n/a |
| Insurance Industry Average Movement | 4.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NEGX.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NEGX.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Ron Loucks | www.nexgenrx.com |
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. The company also provides ancillary services.
NexgenRx Inc. Fundamentals Summary
| NEGX.F fundamental statistics | |
|---|---|
| Market cap | US$14.89m |
| Earnings (TTM) | -US$18.05k |
| Revenue (TTM) | US$10.89m |
1.4x
P/S Ratio-824.8x
P/E RatioIs NEGX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEGX.F income statement (TTM) | |
|---|---|
| Revenue | CA$15.34m |
| Cost of Revenue | CA$3.35m |
| Gross Profit | CA$11.99m |
| Other Expenses | CA$12.01m |
| Earnings | -CA$25.44k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00036 |
| Gross Margin | 78.14% |
| Net Profit Margin | -0.17% |
| Debt/Equity Ratio | 0% |
How did NEGX.F perform over the long term?
See historical performance and comparison